Cargando…
Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes()
During the first year of the pandemic, East Asian countries have reported fewer infections, hospitalizations, and deaths from COVID-19 disease than most countries in Europe and the Americas. Our goal in this paper is to generate and evaluate hypothesis that may explain this striking fact. We conside...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575551/ https://www.ncbi.nlm.nih.gov/pubmed/36328937 http://dx.doi.org/10.1016/j.jbior.2022.100916 |
_version_ | 1784811333812748288 |
---|---|
author | Bhattacharya, Jay Magness, Phillip Kulldorff, Martin |
author_facet | Bhattacharya, Jay Magness, Phillip Kulldorff, Martin |
author_sort | Bhattacharya, Jay |
collection | PubMed |
description | During the first year of the pandemic, East Asian countries have reported fewer infections, hospitalizations, and deaths from COVID-19 disease than most countries in Europe and the Americas. Our goal in this paper is to generate and evaluate hypothesis that may explain this striking fact. We consider five possible explanations: (1) population age structure (younger people tend to have less severe COVID-19 disease upon infection than older people); (2) the early adoption of lockdown strategies to control disease spread; (3) genetic differences between East Asian population and European and American populations that confer protection against COVID-19 disease; (4) seasonal and climactic contributors to COVID-19 spread; and (5) immunological differences between East Asian countries and the rest of the world. The evidence suggests that the first four hypotheses are unlikely to be important in explaining East Asian COVID-19 exceptionalism. Lockdowns, in particular, fail as an explanation because East Asian countries experienced similarly good infection outcomes despite vast differences in lockdown policies adopted by different countries to control the COVID-19 epidemic. The evidence to date is consistent with our fifth hypothesis – pre-existing immunity unique to East Asia – but there are still essential parts of this story left for scientists to check. |
format | Online Article Text |
id | pubmed-9575551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95755512022-10-17 Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes() Bhattacharya, Jay Magness, Phillip Kulldorff, Martin Adv Biol Regul Article During the first year of the pandemic, East Asian countries have reported fewer infections, hospitalizations, and deaths from COVID-19 disease than most countries in Europe and the Americas. Our goal in this paper is to generate and evaluate hypothesis that may explain this striking fact. We consider five possible explanations: (1) population age structure (younger people tend to have less severe COVID-19 disease upon infection than older people); (2) the early adoption of lockdown strategies to control disease spread; (3) genetic differences between East Asian population and European and American populations that confer protection against COVID-19 disease; (4) seasonal and climactic contributors to COVID-19 spread; and (5) immunological differences between East Asian countries and the rest of the world. The evidence suggests that the first four hypotheses are unlikely to be important in explaining East Asian COVID-19 exceptionalism. Lockdowns, in particular, fail as an explanation because East Asian countries experienced similarly good infection outcomes despite vast differences in lockdown policies adopted by different countries to control the COVID-19 epidemic. The evidence to date is consistent with our fifth hypothesis – pre-existing immunity unique to East Asia – but there are still essential parts of this story left for scientists to check. The Authors. Published by Elsevier Ltd. 2022-12 2022-10-17 /pmc/articles/PMC9575551/ /pubmed/36328937 http://dx.doi.org/10.1016/j.jbior.2022.100916 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Bhattacharya, Jay Magness, Phillip Kulldorff, Martin Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes() |
title | Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes() |
title_full | Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes() |
title_fullStr | Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes() |
title_full_unstemmed | Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes() |
title_short | Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes() |
title_sort | understanding the exceptional pre-vaccination era east asian covid-19 outcomes() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575551/ https://www.ncbi.nlm.nih.gov/pubmed/36328937 http://dx.doi.org/10.1016/j.jbior.2022.100916 |
work_keys_str_mv | AT bhattacharyajay understandingtheexceptionalprevaccinationeraeastasiancovid19outcomes AT magnessphillip understandingtheexceptionalprevaccinationeraeastasiancovid19outcomes AT kulldorffmartin understandingtheexceptionalprevaccinationeraeastasiancovid19outcomes |